These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6198814)

  • 1. [Immunology of viral infections].
    Kosiakov PN
    Vestn Akad Med Nauk SSSR; 1983; (12):53-8. PubMed ID: 6198814
    [No Abstract]   [Full Text] [Related]  

  • 2. Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins.
    Chun S; Li C; Van Domselaar G; Wang J; Farnsworth A; Cui X; Rode H; Cyr TD; He R; Li X
    Vaccine; 2008 Nov; 26(48):6068-76. PubMed ID: 19007587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Postvaccinal anti-influenza immunity and its determining factors].
    Kastrikina LN; Lonskaia NI
    Vopr Virusol; 1990; 35(5):362-7. PubMed ID: 2267774
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemagglutinin antigenic determinants of Hong Kong influenza viruses and their role in creating resistance to influenza infection].
    Platonova AL; Isaeva EI; Rovnova ZI; Kosiakov PN
    Vopr Virusol; 1980; (6):712-5. PubMed ID: 6164164
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristic of humoral response of elderly to inactivated influenza vaccine.
    Siennicka J
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):389-94. PubMed ID: 9017157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of inactivated vaccines against influenza].
    Fridman EA; Peradze TV
    Tr Inst Im Pastera; 1982; 58():84-94. PubMed ID: 6764983
    [No Abstract]   [Full Text] [Related]  

  • 7. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology. Flu antibodies stir new hope for treatment, vaccine.
    Leslie M
    Science; 2009 Feb; 323(5918):1160. PubMed ID: 19251602
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-neuraminidase antibody response after administration of a split influenza vaccine.
    Constantinescu C; Ioniţă E; Alexandrescu V; Maţepiuc M; Creţescu L; Niculescu IT
    Arch Roum Pathol Exp Microbiol; 1985; 44(1):37-41. PubMed ID: 4038049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunogenicity of recombinant influenza virus vaccines (author's transl)].
    Higashihara M; Suzuki Y; Saito Y; Igarashi Y; Yoshioka I; Takahashi M; Miki Y
    Uirusu; 1979 Dec; 29(2):127-39. PubMed ID: 550564
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
    Stech J
    Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults.
    Kasel JA; Six HR; Couch RB; Greenberg SB; Cate TR
    Proc Soc Exp Biol Med; 1979 Sep; 161(4):519-21. PubMed ID: 90369
    [No Abstract]   [Full Text] [Related]  

  • 14. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 15. Overcoming maternal antibody interference by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of swine influenza virus.
    Wesley RD; Lager KM
    Vet Microbiol; 2006 Nov; 118(1-2):67-75. PubMed ID: 16939702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variability of the influenza A/Hong Kong virus under laboratory conditions as affected by antibodies].
    Kudriavtseva VK; Nevedomskaia GN; Grinbaum EB; Ivanova NA; Luzianina TIa
    Tr Inst Im Pastera; 1982; 58():47-54. PubMed ID: 7187553
    [No Abstract]   [Full Text] [Related]  

  • 18. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence supporting the inclusion of strains from each of the two co-circulating lineages of H3N8 equine influenza virus in vaccines.
    Daly JM; Yates PJ; Newton JR; Park A; Henley W; Wood JL; Davis-Poynter N; Mumford JA
    Vaccine; 2004 Sep; 22(29-30):4101-9. PubMed ID: 15364463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Properties and biological activity of inactivated influenza vaccine].
    D'iachenko AP
    Mikrobiol Zh (1978); 1982; 44(3):57-9. PubMed ID: 7121321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.